Literature DB >> 34132615

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.

Thomas Perkmann1, Thomas Koller1, Nicole Perkmann-Nagele1, Miriam Klausberger2, Mark Duerkop3, Barbara Holzer4, Boris Hartmann4, Patrick Mucher1, Astrid Radakovics1, Maria Ozsvar-Kozma1, Oswald F Wagner1, Christoph J Binder1, Helmuth Haslacher1.   

Abstract

Keywords:  SARS-CoV-2; neutralizing antibodies; serology

Year:  2021        PMID： 34132615     DOI： 10.1128/Spectrum.00218-21

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN： 2165-0497


× No keyword cloud information.
  4 in total

1.  Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021.

Authors:  Georgina Ireland; Heather Whitaker; Shamez N Ladhani; Frances Baawuah; Sathyvani Subbarao; Ezra Linley; Lenesha Warrener; Michelle O'Brien; Corinne Whillock; Oliver Martin; Paul Moss; Mary E Ramsay; Gayatri Amirthalingam; Kevin E Brown
Journal:  Euro Surveill       Date:  2022-01

2.  Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.

Authors:  Gayatri Amirthalingam; Jamie Lopez Bernal; Nick J Andrews; Heather Whitaker; Charlotte Gower; Julia Stowe; Elise Tessier; Sathyavani Subbarao; Georgina Ireland; Frances Baawuah; Ezra Linley; Lenesha Warrener; Michelle O'Brien; Corinne Whillock; Paul Moss; Shamez N Ladhani; Kevin E Brown; Mary E Ramsay
Journal:  Nat Commun       Date:  2021-12-10       Impact factor: 14.919

Review 3.  Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology.

Authors:  Sundararaj Stanleyraj Jeremiah; Kei Miyakawa; Akihide Ryo
Journal:  J Mol Cell Biol       Date:  2022-08-17       Impact factor: 8.185

4.  Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.

Authors:  Thomas Perkmann; Nicole Perkmann-Nagele; Patrick Mucher; Astrid Radakovics; Manuela Repl; Thomas Koller; Galateja Jordakieva; Oswald F Wagner; Christoph J Binder; Helmuth Haslacher
Journal:  Int J Infect Dis       Date:  2021-07-28       Impact factor: 3.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.